3 terminated, 2 completed, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 3, Completed 2, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow QLT Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib Verteporfin photodynamic therapy, Pegaptanib, Triamcinolone acetonide - Macular Degeneration, Choroidal Neovascularization | Phase 3 | Completed | Novartis Pharmaceuticals | 111 | 2005-09-01 | 2016-03-31 |
| Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. Triamcinolone Acetonide - Age-Related Macular Degeneration | Phase 2 / Phase 3 | Unknown | Canadian Retinal Trials Group | 120 | 2004-01-01 | 2007-07-30 |
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Chemotherapy, tariquidar + paclitaxel/carboplatin, placebo + paclitaxel/carboplatin - Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | Terminated | QLT Inc. | 540 | 2002-06-01 | 2012-05-23 |
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Chemotherapy, tariquidar + vinorelbine, placebo + vinorelbine - Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | Terminated | QLT Inc. | 490 | 2002-06-01 | 2012-05-23 |
| Visudyne® in Occult (VIO) Visudyne for injection - Macular Degeneration | Phase 3 | Completed | QLT Inc. | 364 | 2002-03-01 | 2005-07-21 |
| Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. verteporfin PDT - Basal Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome | Phase 3 | Terminated | QLT Inc. | 2011-03-16 |
Macular Degeneration (3) · Carcinoma, Non-Small-Cell Lung (2) · Basal Cell Nevus Syndrome (1) · Basal cell carcinoma, multiple (1) · Carcinoma, Basal Cell (1) · Choroidal Neovascularization (1)
Drug Therapy (2) · Triamcinolone Acetonide (2) · Verteporfin (2) · tariquidar (2) · Carboplatin (1) · Injections (1) · Paclitaxel (1) · Triamcinolone (1) · Vinorelbine (1) · pegaptanib (1)
Canada (1) · United States (1)
David A Maberley, M.D. (1) · Herma Neyndorff (1) · Joel Naor, MD (1)